Evidence map›Paper›PMID 33379283›Full record

ArticleGenes2020

IMGT

Perrine Pégorier, Morgane Bertignac, Viviane Nguefack Ngoune, Géraldine Folch, Joumana Jabado-Michaloud, Véronique Giudicelli, Patrice Duroux, Marie-Paule Lefranc, Sofia Kossida

Abstract readComparative Study
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. IMGTBiomolecules · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. TR Locus Annotation and Characteristics ofFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Perrine PégorierIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.
Morgane BertignacIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.
Viviane Nguefack NgouneIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.
Géraldine FolchIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.
Joumana Jabado-MichaloudIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.
Véronique GiudicelliIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.ORCID 0000-0002-2258-468X
Patrice DurouxIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.
Marie-Paule LefrancIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.ORCID 0000-0003-0116-9353
Sofia KossidaIMGT®, The International ImMunoGeneTics Information System®, Institut de Génétique Humaine (IGH), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier (UM), 34000 Montpellier, France.ORCID 0000-0003-2482-0022

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adaptive immune response provides the vertebrate immune system with the ability to recognize and remember specific pathogens to generate immunity, and mount stronger attacks each time the pathogen is encountered. T cell receptors are the antigen receptors of the adaptive immune response expressed by T cells, which specifically recognize processed antigens, presented as peptides by the highly polymorphic major histocompatibility (MH) proteins. T cell receptors (TR) are divided into two groups, αβ and γδ, which express distinct TR containing either α and β, or γ and δ chains, respectively. The TRα locus (TRA) and TRδ locus (TRD) of bovine (

Indexed as

Adaptive ImmunityAnimalsCattleEvolution, MolecularGenes, T-Cell Receptor alphaGenes, T-Cell Receptor deltaGenetic LociMolecular Sequence AnnotationSheep, DomesticSpecies SpecificityBos taurusIMGTimmunogeneticsimmunoinformaticsOvis ariesT cell receptorTRA locusTRD locus

Identifiers

PMID33379283
PMCPMC7824213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.